N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Molecular cancer …, 2008 - AACR
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …
被引用次数：67 相关文章
[PDF] researchgate.net

[PDF][PDF] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Mol Cancer …, 2008 - researchgate.net
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

K Bettayeb, H Sallam, Y Ferandin… - Molecular cancer …, 2008 - researchonline.lshtm.ac.uk
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

K Bettayeb, H Sallam, Y Ferandin… - Molecular Cancer …, 2008 - europepmc.org
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …
[PDF] archive.org

[PDF][PDF] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Mol Cancer …, 2008 - scholar.archive.org
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …
[PDF] academia.edu

[PDF][PDF] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Mol Cancer …, 2008 - academia.edu
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …
[PDF] psu.edu

[PDF][PDF] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Mol Cancer Ther, 2008 - Citeseer
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin… - Molecular cancer …, 2008 - pubmed.ncbi.nlm.nih.gov
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …
[PDF] academia.edu

[PDF][PDF] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K Bettayeb, H Sallam, Y Ferandin, F Popowycz… - Mol Cancer …, 2008 - academia.edu
Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in
tumors. Ten low molecular weight pharmacologic inhibitors of CDKs are currently in clinical …

[引用][C] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

K BETTAYEB, H SALLAM… - Molecular …, 2008 - American Association for Cancer …